1. Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine, New York, New York, USA;
2. Eli Lilly and Company, Indianapolis, Indiana, USA;
3. Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada;
4. Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan;
5. Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany;
6. The University of Chicago Medicine Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois, USA;
7. Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt/Main, Germany;
8. Experimental Medicine Division, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.